Literature DB >> 1285007

Pardaxin-stimulated calcium uptake in PC12 cells is blocked by cadmium and is not mediated by L-type calcium channels.

B Nikodijevic1, D Nikodijevic, P Lazarovici.   

Abstract

Pardaxin is an excitatory neurotoxin which triggers neurotransmitter release as a result of voltage-dependent pore formation within the neuronal membrane. We have used several pharmacological manipulations of calcium influx to characterize pardaxin pore activity in PC12 cells in culture. Pardaxin stimulates the uptake of radioactive calcium into PC12 cells in a dose dependent fashion (ED50 of 0.4 microM). This stimulation is partially inhibited by nifedipine, a blocker of L-type calcium channels. Effective blockade of pardaxin stimulation was produced by the inorganic calcium channel blockers cadmium (IC50 of 10 microM) and nickel (2 mM). Homologous down regulation of L-calcium channels by the agonist Bay K-8644, inhibited the subsequent stimulation of calcium uptake by this drug, but not by pardaxin. A fluorometric analysis of pardaxin pore formation in unilamellar large liposomes indicates pardaxin pores are blocked by cadmium (10-200 microM). These data distinguish between pardaxin pores and L-type calcium channels in PC12 cells. We suggest pardaxin as a pharmacological ionophore tool to modulate neuronal calcium homeostasis and neurotransmitter release.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285007     DOI: 10.1515/jbcpp.1992.3.4.359

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  2 in total

Review 1.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

2.  The antimicrobial peptide pardaxin exerts potent anti-tumor activity against canine perianal gland adenoma.

Authors:  Chieh-Yu Pan; Chao-Nan Lin; Ming-Tang Chiou; Chao Yuan Yu; Jyh-Yih Chen; Chi-Hsien Chien
Journal:  Oncotarget       Date:  2015-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.